Staying informed is also a great way to stay healthy. Keep up-to-date with all the latest health news here.
05 May
A review in Annals of Internal Medicine finds most CGRP-targeted therapies cut migraine days by about two per month. Evidence for older medications was weaker, according to researchers.
04 May
Two new studies find widespread social media exposure to inhalants is impacting young teens, especially girls.
01 May
In a new study, breast cancer survivors who completed a three-month high-intensity resistance training program improved strength, mobility, balance, and muscle mass—supporting a faster return to everyday activities.
U.S. Supreme Court Justice Samuel Alito Jr. issued an order Monday that allows patients to continue accessing abortion pill, mifepristone, by mail, for now.
The one-sentence order pauses a Friday ruling from the U.S. Court of Appeals for the Fifth Circuit in New Orleans that required an in-person pickup for mifepristone, according to T...
Chronic migraine can be difficult to treat — but new research is helping identify the most effective options.
In a large new review, published today in the Annals of Internal Medicine, researchers analyzed 43 clinical trials involving adults with chronic migraine, defined as headaches on 15 or more days a month.
The st...
Alcoholic beverages in the United States carry a warning label, but you’d be forgiven if they leave little impression.
In place since 1988, the label states the risks of drinking during pregnancy or while driving, along with a general notice that alcohol “may cause health problems.”
These small labels often go unnot...
A new combination drug therapy could help people with inflammatory bowel disease (IBD) for whom other medicines have stopped working, according to a pair of new studies.
The treatment combines two drugs already approved to treat inflammatory diseases, guselkubam (Tremfya) and golimumab (Simponi), researchers are reporting today at a joint ...
Ozempic can help people who are battling alcoholism, a major new clinical trial has concluded.
People with alcohol use disorder taking semaglutide (Ozempic/Wegovy) had significantly fewer heavy drinking days compared to patients assigned a placebo, researchers reported May 2 in The Lancet.
People on semaglutide also dr...
The United States is moving quickly toward losing its status as a measles-free nation, a new study says.
The nation has missed four of seven markers set by the U.S. Centers for Disease Control and Prevention (CDC) after experts declared measles eradicated in 2000, researchers report in The Lancet.
These include a surge in me...